Fructosamine Test Market

Future Market Insights

Key Insight

The fructosamine test market is projected to grow from USD 286.9 million in 2025 to USD 416.6 million by 2035, at a CAGR of 3.8%. Diabetes II will dominate with a 55.1% market share, while blood serum will lead the sample segment with a 62.0% share.

October 07, 2025

Anurag Sharma

316 Pages

Cite this Report

Fructosamine Test Market

https://www.futuremarketinsights.com/reports/fructosamine-test-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abcam plc
Asahi Kasei Pharma Corporation (EKF DIAGNOSTICS)
Eurolyser Diagnostica GmbH
Kamiya Biomedical Company
Randox Laboratories Ltd
Zhejiang Kangte Biotechnology Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Fructosamine Test Market

Key Players

Similar Industry Reports